KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Palvella Therapeutics (PVLA) Change in Acquisitions & Divestments: 2018-2024

Historic Change in Acquisitions & Divestments for Palvella Therapeutics (PVLA) over the last 5 years, with Mar 2024 value amounting to $9.0 million.

  • Palvella Therapeutics' Change in Acquisitions & Divestments fell 33.31% to $9.0 million in Q1 2024 from the same period last year, while for Mar 2024 it was $30.5 million, marking a year-over-year decrease of 26.82%. This contributed to the annual value of $35.0 million for FY2023, which is 24.14% up from last year.
  • Latest data reveals that Palvella Therapeutics reported Change in Acquisitions & Divestments of $9.0 million as of Q1 2024, which was down 18.19% from $11.0 million recorded in Q4 2023.
  • In the past 5 years, Palvella Therapeutics' Change in Acquisitions & Divestments registered a high of $28.4 million during Q1 2020, and its lowest value of $4.8 million during Q2 2022.
  • Moreover, its 3-year median value for Change in Acquisitions & Divestments was $7.7 million (2022), whereas its average is $9.0 million.
  • Per our database at Business Quant, Palvella Therapeutics' Change in Acquisitions & Divestments skyrocketed by 910.91% in 2020 and then crashed by 70.02% in 2023.
  • Quarterly analysis of 4 years shows Palvella Therapeutics' Change in Acquisitions & Divestments stood at $15.8 million in 2020, then reached $6.3 million in 2022, then skyrocketed by 74.62% to $11.0 million in 2023, then crashed by 33.31% to $9.0 million in 2024.
  • Its Change in Acquisitions & Divestments was $9.0 million in Q1 2024, compared to $11.0 million in Q4 2023 and $5.1 million in Q3 2023.